News | November 11, 2014

TIDI Products Acquires CFI, Maker of Cath Lab Radiation Protection Equipment

Acquisition enhances radiation protection offerings in the cath lab

November 11, 2014 — TIDI Products LLC has acquired CFI Medical Solutions (CFI) of Fenton, Mich., a diversified medical device manufacturer and engineering resource for hospitals, distributors and global original equipment manufacturers.

CFI has expertise in the design, engineering and manufacturing of radiation protection, infection prevention and patient positioning systems that help clinicians improve the effectiveness of their practices and healthcare systems. The company’s innovation process is collaborative, developing products by working side-by-side with clinicians and physicians.

“We’ve seen some of the value added innovations, such as C-Armor and Zero-Gravity that CFI has developed in partnership with its healthcare professional network” said Kevin McNamara, president and CEO of TIDI. “We look forward to adopting CFI’s culture of innovative thinking throughout our business to further enhance TIDI’s mission of supporting caregivers and preventing infections.”

C-Armor is an expandable and collapsible sterile pouch that adheres to the patient drape at or above the level of the sterile field line during surgical procedures. Zero-Gravity is a suspended radiation protection system that provides greater protection to clinicians during fluoroscopic procedures.

Headquartered in Neenah, Wis., TIDI plans to continue CFI’s engineering and manufacturing operations for its domestic and international customers. CFI employs approximately 300 people at its manufacturing locations in Fenton, Mich., and its Changshu Yushan Protection Products Co. Ltd. facility in Changshu, China.

For more information: www.tidiproducts.com, www.cfimedical.com

Related Content

Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Medtronic Announces Japanese Regulatory Approval for In.Pact Admiral Drug-Coated Balloon
News | Drug-Eluting Balloons| September 13, 2017
Medtronic plc announced that the In.Pact Admiral Drug-Coated Balloon (DCB) received approval from the Japanese Ministry...
PQ Bypass Reports Positive Results for Detour System in Patients With Long Femoropopliteal Blockages
News | Peripheral Artery Disease (PAD)| September 13, 2017
A subset analysis of the DETOUR I clinical trial showed promising safety and effectiveness results of PQ Bypass’ Detour...
Overlay Init